Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on The Iceland Tribune.
Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to...
Lucinity and Creditinfo Partner to Integrate PEP Screening Seamlessly into AI Workflows
REYKJAVIK, Iceland , May 07, 2025 (GLOBE NEWSWIRE) -- Lucinity, a global leader in AI-driven compliance software, has partnered with Creditinfo, a trusted and leading provider of credit and risk intelligence solutions, to integrate access to...
Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established
Stellantis Reports First Half 2025 Results Reflecting External Headwinds and Ongoing Recovery Actions; Financial Guidance Re-Established Net revenues of €74.3 billion, down 13% compared to H1 2024 primarily driven by Y-o-Y declines in North...
Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C
CELEBRATION, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare diseases, announced the company submitted...
BSTR Miner Launches Innovative Ethereum Mining Service with AI-Optimized Staking-Style Rewards
CHICAGO, July 16, 2025 (GLOBE NEWSWIRE) -- BSTR Miner today launched its next-generation Ethereum cloud service, integrating mining and staking operations through an AI-driven resource engine. The service offers 24-hour payout cycles with contract...
Oculis Publishes Invitation to the Annual General Meeting
ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11,...
Lucinity Featured in Chartis Research FinCrime and Compliance 50 Ranking for 2025
REYKJAVIK, Iceland, May 08, 2025 (GLOBE NEWSWIRE) -- Lucinity has been listed among the top 50 Financial Crime and Compliance (FCC) companies in the 2025 FCC50 ranking by Chartis Research. This recognition reflects Lucinity’s continued ability to...
Oculis Reports Q1 2025 Financial Results and Provides Company Update
The recent R&D Day (replay) showcased material progress across all three core assets and highlighted potential first-in-class neuroprotection treatment in neuro-ophthalmology, an area of high unmet medical need, thanks to Privosegtor’s (OCS-05)...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
Restraint, Diplomacy, and Restoring Arctic Exceptionalism
Back to Publications Left to Right – Cynthia Lazaroff (Board Member of the Arctic Institute), Pavel Devyatkin (Senior Associate at The Arctic Institute), Anatol Lieven (Director of the Eurasia Program at the Quincy Institute), Jennifer Spence...
Allied lawmakers explore NATO's strategic imperatives in North Atlantic during Nordic visit
10 July 2025 NATO Allies have rightly identified Russia as the most significant and direct threat to Euro-Atlantic security. Today, Russia’s increasingly aggressive military and political posture toward NATO Allies poses an acute 360-degree...
Owner: NATO Parliamentary Assembly
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025 SELARSDI is approved for all...
QFSCOIN Launches the Most Profitable Platform for Yielding Crypto in 2025, Designed for Global Investors to Earn BTC, LTC, and DOGE coin
New York City, NY, July 23, 2025 (GLOBE NEWSWIRE) -- Dogecoin (DOGE) is making headlines again, this time, not just for memes and social media hype. Recent on-chain data reveals that whales, the largest investors in the market, are quietly...
AirAsia partners with Plan3 to transform the passenger experience during flight disruptions
Enhancing Passenger Support with Innovative Disruption Management Solutions. REYKJAVIK, 105, ICELAND, February 13, 2025 /EINPresswire.com/ -- Flight delays and cancellations affect hundreds of millions of passengers each year, costing the global...
Century Aluminum Company Closes Private Offering of $400 Million of Senior Secured Notes
CHICAGO, July 22, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) (“Century”) announced today that it closed its private offering of 6.875% senior secured notes due August 2032 (the “Secured Notes”) for gross proceeds of $400...
Joint statement on behalf of international partners on the Occupied Palestinian Territories
SLOVENIA, July 21 - The suffering of civilians in Gaza has reached new depths. The Israeli government’s aid delivery model is dangerous, fuels instability and deprives Gazans of human dignity. We condemn the drip feeding of aid and the inhumane...
Owner: Slovenian Government